These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29880269)

  • 21. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
    Greene CL; Worrell SG; DeMeester TR
    Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barrett's oesophagus and proton pump inhibitors: a pathological perspective.
    Shepherd NA
    Gut; 2000 Feb; 46(2):147-9. PubMed ID: 10644302
    [No Abstract]   [Full Text] [Related]  

  • 24. Surgical management of gastroesophageal reflux disease/Barrett's esophagus.
    D'Cunha J; Andrade RS; Maddaus MA
    Minerva Chir; 2011 Feb; 66(1):7-19. PubMed ID: 21389921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
    Akın H; Aydın Y
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
    Morganstern B; Anandasabapathy S
    Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for Barrett's esophagus.
    Rubenstein JH
    Curr Opin Gastroenterol; 2014 Jul; 30(4):408-14. PubMed ID: 24859804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology and pathophysiology of Barrett esophagus].
    Freys SM; Fuchs KH; Heimbucher J; Fein M; Thiede A
    Zentralbl Chir; 2000; 125(5):406-13. PubMed ID: 10929624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of gastroesophageal reflux control through tailored proton pump inhibition therapy or fundoplication in patients with Barrett's esophagus.
    Baldaque-Silva F; Vieth M; Debel M; Håkanson B; Thorell A; Lunet N; Song H; Mascarenhas-Saraiva M; Pereira G; Lundell L; Marschall HU
    World J Gastroenterol; 2017 May; 23(17):3174-3183. PubMed ID: 28533674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia.
    Fedorova E; Watson TJ
    Surg Clin North Am; 2021 Jun; 101(3):391-403. PubMed ID: 34048760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GORD and Barrett's oesophagus: does oesophageal motility matter?
    Rodríguez-Téllez M
    Rev Esp Enferm Dig; 2002 Apr; 94(4):180-7. PubMed ID: 12185929
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings from an international conference on ablation therapy for Barrett's mucosa: Brittany, France, 31 August - 2 September 1997.
    Bremner CG; Demeester TR
    Dis Esophagus; 2017 Nov; 11(1):1-27. PubMed ID: 29040490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
    Kashin SV; Ivanikov IO
    Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barrett esophagus.
    Splittgerber M; Velanovich V
    Surg Clin North Am; 2015 Jun; 95(3):593-604. PubMed ID: 25965132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.